PhRMA urges FDA to work internationally to harmonize any change in the approach to premarket safety analytics.
CDRH researchers analyze the causes of medical device shortages before and during the pandemic and call for more information from manufacturers to mit...
The Coalition for Health AI releases a summary of stakeholder discussions on issues that could lead to guidance to enable trustworthy artificial intel...
FDA defends criticism from three former FDA Team Biologics inspectors who left the agency over working conditions and complaints over lack of training...
Federal Register notice: FDA announces that AstraZeneca redeemed a priority review voucher for Imjudo (tremelimumab), which was approved 10/23.
Federal Register notice: FDA makes available a final guidance on pharmacokinetic-based criteria for supporting alternative dosing regimens for program...
FDA asks Oncopeptides to withdraw the accelerated approval of multiple myeloma therapy Pepaxto (melphalan flufenamide) after a confirmatory trial fail...
An Associated Press story says FDA has granted fewer accelerated approval NDAs/BLAs after taking new steps to tighten control over the expedited pathw...